FLUOX-PMS
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Fluoxetine
What it measured
Main measures
Time to confirmed disease progression, defined as either
Other measures (1)
- Changes in global brain atrophy and diffusion tensor imaging.
MRI lesionsBrain volume loss
Who could take part
Progressive MS
Inclusion: 1. Signed written informed consent. Exclusion: 1.Pregnancy or lactation
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
•at least a 20 % increase in the timed 25-Foot Walk (T25FW),
Papers
Loading reviews and guidelines…
Related trials
- MS-SMART
Phase 2 · Completed
Missed its main goal
- EPO-ProgMS
Phase 2 · Status unknown
No result found
- A pilot single-centre randomised controlled trial of reco…
Phase 2 · Stopped early
Stopped early
- Single Oral Doses Study of Nerispirdine on Visual Functio…
Phase 2 · Completed
No result found
- Amiloride in MS
Phase 4 · Completed
No result found
- Fluoxetine in progressive multiple sclerosis: a placebo-c…
Completed (inferred)
Result in a paper, not read yet
History
Started
Sept 2011
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error